Immunotherapy in Renal Cell Carcinoma from Poverty to the Spoiled of Choice
Francesco Massari(Altera (United States)), Antonio López-Beltrán(University of Córdoba), Rodolfo Montironi(Marche Polytechnic University), Alessia Cimadamore(University of Udine), Ana Blanca(Instituto Maimónides de Investigación Biomédica de Córdoba), Vincenzo Di Nunno(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Liang Cheng(Brown University), Veronica Mollica(Medica (Italy))
Cited by 18
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289